
An International Publisher for Academic and Scientific Journals
Author Login
SAS Journal of Medicine | Volume-11 | Issue-02
Evaluating Diabetes Prevention Strategies in the NHS 'Healthier You' Programme and Risk Assessment Tools
Dr Jalal Alam, Dr Ahmed Mohamed Mohamed Metwaly
Published: Feb. 26, 2025 |
53
46
DOI: https://doi.org/10.36347/sasjm.2025.v11i02.008
Pages: 128-132
Downloads
Abstract
It has become imperative for healthcare systems globally to reduce incidence of diabetes due it’s rise and associated complications. Several measures and interventions have been suggested to prevent the progression of Non-Diabetic Hyperglycaemia to Type 2 Diabetes Mellitus. In England, the NHS Diabetes Prevention Programme (NHS DPP), launched in 2016, aims to reduce diabetes incidence through behavioural interventions focusing on weight loss, dietary improvements, and increased physical activity. This is based on evidence from international studies, including the Da Qing Study and Finnish Diabetes Prevention Study, which have proven that lifestyle modifications are the most effective strategy for diabetes prevention. A service evaluation of the NHS DPP revealed that while the program led to significant reductions in weight and HbA1c, participation and retention rates remained suboptimal, particularly among ethnic minority groups. Challenges include variability among provider delivery, the need for better risk assessment tools, and inadequate patient engagement. Improving referral pathways, introducing digital interventions, and increasing public awareness through targeted opportunistic campaigns may improve participation and effectiveness. Furthermore, there are several risk assessment tools for early detection of high-risk individuals like FINDRISK and CANRISK. However, local population characteristics must be considered. Studies indicate that the Leicester Risk Assessment Score is the most effective in predicting NDH in England, making it a viable tool for widespread use in general practice. Proactive screening strategies and refining risk models could enhance the NHS DPP’s impact, ultimately reducing the burden of diabetes on healthcare systems.